LEADER 03900nam  2201201z- 450 
001 9910566469503321
005 20220506
035   $a(CKB)5680000000037685
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81213
035   $a(oapen)doab81213
035   $a(EXLCZ)995680000000037685
100   $a20202205d2022      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aTargeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 online resource (298 p.)
311 08$a3-0365-3517-9 
311 08$a3-0365-3518-7 
330   $aDysregulation of Wnt signaling is known to be associated with various cancers. As such, identification of novel Wnt pathway targets in cancer and better characterization of already-known targets present exciting, emerging opportunities for cancer treatment. In this Special Issue, we feature papers which discuss the role of Wnt signaling and associated targets in cancer metabolism, tumor immune response, and tumor microenvironment. Papers discussing a range of Wnt-mediated cancers, including those of the colon, liver, pancreas, synovium, bladder, etc., are included.
517   $aTargeting Wnt Signaling in Cancer
606   $aMedicine and Nursing$2bicssc
606   $aPharmacology$2bicssc
610   $aAML
610   $aangiogenesis
610   $aanti-angiogenic therapy
610   $aAPC
610   $aastrocytic brain tumors
610   $acancer
610   $acancer stem cells
610   $acancer therapy
610   $aCBP
610   $acell adhesion
610   $acolitis
610   $acolon cancer
610   $acolorectal
610   $acolorectal cancer
610   $aDKKs
610   $adrug discovery
610   $adrug target
610   $aEMT
610   $afibrosis
610   $afungi secondary metabolite derivative
610   $agastrointestinal cancers
610   $aGSK3?
610   $aHBV
610   $ahepatitis B virus
610   $aIBD
610   $aimmune checkpoint inhibitor
610   $aimmunotherapy
610   $aimmunotherapy resistance
610   $ainvasion and metastasis
610   $ajust-right signaling
610   $aL1
610   $aLgr5
610   $aliver cancer
610   $amicroenvironment
610   $amolecular targeting
610   $amolecular therapeutics
610   $aMusashi
610   $aMYC
610   $aNCB-0846
610   $aNF-?B
610   $aNotch signaling
610   $ap300
610   $apancreatic cancer
610   $apancreatic stellate cells
610   $apancreatitis
610   $aporcupine
610   $aprecision medicine
610   $aR-spondin
610   $aRNA-binding proteins
610   $aserrated
610   $asignaling
610   $asynovial sarcoma
610   $aTCF/LEF
610   $atherapeutic targeting of Wnt signaling
610   $aTNIK
610   $atumor immunology
610   $atumor metabolism
610   $aurothelial cancer
610   $avitamin D
610   $awnt
610   $aWnt
610   $aWnt signaling
610   $aWnt target genes
610   $aWnt/beta-catenin signaling
610   $a?-catenin
610   $a?-catenin mutations
610   $a?-catenin paradox
615  7$aMedicine and Nursing
615  7$aPharmacology
700   $aKahn$b Michael$4edt$01310152
702   $aLai$b Keane$4edt
702   $aKahn$b Michael$4oth
702   $aLai$b Keane$4oth
906   $aBOOK
912   $a9910566469503321
996   $aTargeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles$93040916
997   $aUNINA